Business Wire

UGANDA-IMMIGRATION

Share
Discover diverse culture in Uganda with Uganda Immigration Services

When it comes to Uganda, travelers will immediately remember a vast expanse of savannah across the country, a diverse ethnic culture, and a wealth of wildlife. Besides safari tours, most international travelers also visit this beautiful country to discover the diverse culture in Uganda.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220618005004/en/

The culture of Uganda and its age-old tradition attract many foreign tourists

Uganda tourism statistics show a gradual increase in the number of tourists to Uganda in 2021. Thanks to the reopening of tourism, Uganda is expected to welcome more international travelers in 2022.

The culture of Uganda is made up of more than 50 tribes, including Ugandan indigenous people, and a small population migrated from Europeans, Asians, and Arabians. There are four main ethnic groups in Uganda, including the Bantu, the Nilotics, the NiloHamitics, and the Hamites.

The importance of culture in Uganda has been recognized through the cultural values it brings to the community. In this diverse culture, the traditional dance has always been a part of Uganda's identity. Each ethnic community has distinctive dances with different meanings and purposes, making it easy for visitors to distinguish between the tribes. Local people often integrate these dances into their day-to-day life to keep and share cultural values with different generations.

The "Gomesi" and the "Kanzu" are traditional costumes in Uganda. The "Gomesi" is a national dress in Uganda that Ugandan women often wear at events or ceremonies, while "Kanzu" is worn by Ugandan men during cultural functions.

Some cultural sites for travelers to immerse in cultures and traditions in Uganda

The best way for travelers to understand the diversity of new cultures and traditions in Uganda is to interact with the local community.

Going off-the-beaten-path in Karamoja village, travelers can discover the unique culture of the local people through their dress code, traditional dances, and local crafts. Karamojong people are mainly semi-nomadic pastoralists living in the North Eastern region of Uganda for hundreds of years.

The Ndere Cultural Center is set up with the primary purpose of maintaining Uganda's culture alive. This Center is an ideal destination for travelers to understand different cultures in Uganda . They can enjoy the cultural song and dance performances with handmade instruments from various tribes in Uganda.

Before departing, travelers should consider purchasing travel insurance that will help them cover their medical expenses should things go wrong and provide them additional benefits on their cultural tours in Uganda.

Uganda Immigration Services recommends tourists to apply for Uganda e Visa online beforehand

Travelers should keep in mind that they need to get a visa to enter Uganda. The fastest and most convenient way to obtain a visa is to apply for Uganda e Visa online .

“I had difficulty applying for a Uganda e-Visa on the Government website. Fortunately, experts from Uganda Immigration Services have helped me simplify the e-Visa application process, so I can obtain an e-Visa easier at a reasonable Uganda visa fee. I was definitely impressed with their enthusiasm and professionalism.”, said Key Smith.

Experts from Uganda Immigration Services also suggest that travelers should check Uganda visa requirements so that their visa application will be processed faster without interruption.

Uganda Immigration Services provides customers the comprehensive service of e-visa, travel insurance, sim card, and car pick up. From now on, travelers can expect to get an e-visa to the Pearl of Africa easier than ever before.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse

Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti

Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH7.12.2025 17:00:00 CET | Press release

AOP Health continues to advance its clinical research program in myeloproliferative neoplasms, a special group of rare blood cancers. The company, specialized in rare diseases, presented the results of two scientific investigations at the 67th American Society of Hematology Association (ASH) Annual Meeting 2025 held in Orlando, FL, USA. The results provide new insights in treatment strategies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207587915/en/ Dr. Martin Steinhart, CEO AOP Health; Photo credit: AOP Health/Studio Koekart ROP-ET and BESREMI PASS One of the clinical studies, ROP-ET, examined the use of ropeginterferon alfa-2b in people with essential thrombocythemia (ET), a disease in which the body produces too many platelets. The trial, a prospective, multicenter, single-arm phase III study, investigated the safety and efficacy of ropeginterferon alfa-2b in ET patients unable to receive available cytoreductive th

CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release

Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships

Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release

Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On

Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release

52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye